NEW YORK, NY / ACCESSWIRE / April 16, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Corcept Therapeutics Incorporated (NASDAQ: CORT). The settlement provides for a fund of $14,000,000 to benefit class members. For the purposes of the settlement, the class is defined as: all persons who purchased or otherwise acquired common stock or options to purchase common stock of Corcept Therapeutics Incorporated during the Settlement Class Period, August 2, 2017 to January 31, 2019, inclusive.
If you are a class member as defined above, you may be entitled to a pro-rata share of the settlement fund. In order to receive a share of the settlement, you must file a claim form by May 13, 2024.
For more details on the settlement, including a copy of the claim form, please visit: https://zlk.com/settlement-form/?redirect=aHR0cHM6Ly96bGsuY29tL3NldHRsZW1lbnQvY29yY2VwdC10aGVyYXBldXRpY3MtaW5jb3Jwb3JhdGVkLXNldHRsZW1lbnQ=&spr=324&wire=1&ticker=CORT
Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
https://zlk.com/
SOURCE: Levi & Korsinsky, LLP